← Evidence map

ReviewDrug design, development and therapy2013

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

Annalisa Capuano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24068868